Mustang Bio Company

Mustang Bio is a clinical-stage biopharmaceutical company .
Industry:
CAR-T
Investors Number:
4
Last Funding Type:
Post-IPO Debt
Total Funding:
204300000
Funding Status:
IPO
Headquarters:
New York, New York, United States
Founded Date:
2015-01-01
Last Funding Date:
2022-03-08
Estimated Revenue:
$10M to $50M